These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 769244)

  • 1. [Clinical trial of antihypertensive drugs].
    Therapie; 1975; 30(5):631-52. PubMed ID: 769244
    [No Abstract]   [Full Text] [Related]  

  • 2. The sympathetic nervous system in hypertension: differing effects of drug treatment.
    Sleight P
    Eur Heart J; 1998 Jun; 19 Suppl F():F39-44. PubMed ID: 9651734
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical pharmacology of antihypertensive agents and their therapeutic indications].
    Roland E; Weiss Y; Simon A; Safar M
    Coeur Med Interne; 1978; 17(4):585-603. PubMed ID: 367698
    [No Abstract]   [Full Text] [Related]  

  • 4. Antihypertensive drugs and the sympathetic nervous system.
    Del Colle S; Morello F; Rabbia F; Milan A; Naso D; Puglisi E; Mulatero P; Veglio F
    J Cardiovasc Pharmacol; 2007 Nov; 50(5):487-96. PubMed ID: 18030057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of antihypertensive therapies on the sympathetic nervous system.
    de Champlain J; Karas M; Toal C; Nadeau R; Larochelle P
    Can J Cardiol; 1999 Mar; 15 Suppl A():8A-14A. PubMed ID: 10205251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High blood pressure management: potential benefits of I1 agents.
    Esler M
    J Hypertens Suppl; 1998 Aug; 16(3):S19-24. PubMed ID: 9747906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Increased activity of the sympathetic nervous system and the possibilities for therapeutic influence].
    Soucek M; Nevrlka J; Rihácek I; Frána P; Plachý M
    Vnitr Lek; 2007 May; 53(5):554-9. PubMed ID: 17642445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular and renal benefits are additive using intensive blood pressure control and incremental glucose control in type 2 diabetic patients.
    Cardiovasc J Afr; 2008; 19(5):284-6. PubMed ID: 18997995
    [No Abstract]   [Full Text] [Related]  

  • 9. A clinical trial of polythiazide and guanoxan in the treatment of hypertension.
    Mann RD; Jackson D
    Practitioner; 1966 Feb; 196(172):293-9. PubMed ID: 5322962
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of angiotensin receptor inhibitors on cardiovascular endpoints--current and future evidence].
    Karlócai K
    Orv Hetil; 2003 May; 144(18 Suppl 1):901-3. PubMed ID: 12785235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antihypertensive agents--principles of combination drug therapy].
    Ruskoaho H
    Duodecim; 2000; 116(24):2826-30. PubMed ID: 12077888
    [No Abstract]   [Full Text] [Related]  

  • 12. [Long-term drug therapy of arterial hypertension including patient compliance].
    Linss G; Kiesewetter R
    Z Arztl Fortbild (Jena); 1984; 78(24):1047-53. PubMed ID: 6442069
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prospects for pharmacological effects on renin-angiotensin and sympathetic nervous systems in patients with arterial hypertension].
    Chikhladze NM
    Ter Arkh; 2000; 72(12):67-9. PubMed ID: 11201840
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of hypertension. 3. Antihypertensive agents affecting catecholamine metabolism].
    Faulhaber HD; Gawellek F; Singer P
    Dtsch Gesundheitsw; 1968 Oct; 23(43):2017-24. PubMed ID: 5732807
    [No Abstract]   [Full Text] [Related]  

  • 15. Centrally acting antihypertensives: not obsolete after all.
    Schachter M
    Int J Clin Pract; 1998; 52(3):192-5. PubMed ID: 9684437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metabolic and cardiovascular profile in antihypertensive treatment with urapidil].
    Gerber A; Weidmann P; Marone C; Uehlinger D; Riesen W
    Therapie; 1990; 45 Suppl 2():219-27. PubMed ID: 2187268
    [No Abstract]   [Full Text] [Related]  

  • 17. Targeting Ouabain- and Adducin-dependent mechanisms of hypertension and cardiovascular remodeling as a novel pharmacological approach.
    Ferrari P; Ferrandi M; Valentini G; Manunta P; Bianchi G
    Med Hypotheses; 2007; 68(6):1307-14. PubMed ID: 17097240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple risk factor intervention trial.
    Mishkel MA
    Can Med Assoc J; 1983 May; 128(10):1140-1. PubMed ID: 6340810
    [No Abstract]   [Full Text] [Related]  

  • 19. Antihypertensives.
    Daniels V; Casey A
    Phys Med Rehabil Clin N Am; 1999 May; 10(2):319-35, viii. PubMed ID: 10370934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renin-angiotensin system in the brain as a new target of antihypertensive therapy.
    Ito S; Komatsu K; Yajima Y; Hirayama A
    Hypertens Res; 2008 Aug; 31(8):1487-8. PubMed ID: 18971519
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.